Follow-up examination after treatment for malignant neoplasms

MESH PheWeb

Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 Z08

Cause of death: ICD-10 Z08

2673

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10 ; C.O.D: 10

2673

Check minimum number of events None

2673

Include endpoints None

2673

Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF4

Parent code in ICD-10 Z[0-1]

Similar endpoints

↥

List of similar endpoints to Follow-up examination after treatment for malignant neoplasms based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	2592	1495	1097
Unadjusted prevalence (%)	0.84	0.86	0.81
Mean age at first event (years)	63.61	60.10	68.40

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	2.93 [2.01, 4.28]	2.8e-8	459
15 years	0.01	1.27 [0.88, 1.85]	2.0e-1	176
5 years	0.00	3.35 [2.54, 4.43]	1.6e-17	175
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: Z21_FOLLOW__EXAM_TREAT_MALIG_NEOPLASMS – Follow-up examination after treatment for malignant neoplasms
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Follow-up examination after treatment for malignant neoplasms
after Follow-up examination after treatment for malignant neoplasms

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Follow-up examination after treatment for malignant neoplasms

↥